louisiana semaglutide ileus class action nausea in glp-1 gi obstruction lawsuit gastrointestinal gastric intestinal obstruction attorney louisiana Ozempic GLP-1 & Gastroparesis-mvanhaasteren.nl glp-1 class action in – louisiana semaglutide nausea law firm louisiana semaglutide class action glp-1

Ch cm thy rt vui

Researchers note a serious dearth of studies examining the aftermath of quitting these medications

Eli Lilly may submit its dossier for first round evaluation after TRIUMPH-3 (pending positive outcomes), so at the earliest, late 2026 seems like a realistic estimation, if not later into early 2027 after TRIUMPH-5 has finished

PMID: 11718984

S2CID 29816004

View image online ( Woman's hands holding drug injector In late 2025, the nonprofit KFF health-policy organization published results of a poll that found that about one in eight Americans were taking GLP-1 medications for weight loss or other health condition